1. A first-in-human single ascending dose study of a monoclonal antibody against the ANGPTL3/8 complex in subjects with mixed hyperlipidemia. (August 2022) Authors: Gaudet, D.; Gonciarz, M.; Shen, X.; Mullins, G.; Leohr, J.K.; Benichou, O.; Beyer, T.; Ruotolo, G. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative effects of cholesteryl ester transfer protein inhibition, statin and ezetimibe therapy on atherogenic and protective lipid factors: The accentuate trial. (September 2016) Authors: Nicholls, S.; Ray, K.; Ballantyne, C.; Beacham, L.; Miller, D.; Ruotolo, G.; Riesmeyer, J. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0198 Baricitinib Effects on Lipid and NMR-Measured Lipoprotein Profiles in A Phase 3 Study in Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Taylor, P.; Keystone, E.; Tanaka, Y.; van der Heijde, D.; Zhong, J.; Thanabalasundrum, S.; Ruotolo, G.; Schlichting, D.; Rooney, T.P.; Macias, W.L.; Zuckerman, S.; de Bono, S.; Weinblatt, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗